In this study, we have established that immunomodulators, HCQ, and CQ significantly reduced the transcriptional activity of the c-myc predominantly stabilizing the G4 in upstream of the promoter region of the gene and significantly restricting the progression of cancer. This evidence concerns the gene MYC and cancer.